QR-010: Proof-of-concept trial started

ProQR began the open-label, international, proof-of-concept PQ-010-002 trial to evaluate thrice-weekly QR-010 applied directly to the nasal mucosa for 4 weeks in >=16 patients with 1-2 copies of the d...